http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2261713-C1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 |
| filingDate | 2004-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f681c89fbbd09ba2e6fd887084b2ea6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84e3930cb7315383e9c805663d594234 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77a0a64b854d855fc40dd9070316d835 |
| publicationDate | 2005-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2261713-C1 |
| titleOfInvention | Method for treatment of severe form of acute optical neuritis in patient with cerebrospinal sclerosis |
| abstract | FIELD: medicine, ophthalmology. n SUBSTANCE: method involves intravenous administration of metypred in every other day being in the 1-st and 3-d days the dose is by 500.0 mg, in 5-th and 7-th day - by 250.0 mg, and in 9-th and 10-th day - by 125 mg. In onset of metypred administration dexamethasone in the dose 1.0 ml is administrated by retrobulbar route every day for 10 days. Also, method involves pterygopalatine blockade including dexamethasone, ketorol, emoxipine, lidocaine, dalargin in doses 1.0; 1.0; 1.0; 2.0 ml and 0.001 g every day for 5 days and then 3 blockades in every other day, one blockade per a day. Method expands assortment of therapeutic approaches in treatment of acute optical neuritis in patients with cerebrospinal sclerosis. n EFFECT: improved and enhanced treatment method. n 1 tbl, 1 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2494709-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021211006-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008091177-A1 |
| priorityDate | 2004-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.